The abstract is read at the publisher; the summary is JClub's.
DTS integrated matched serum peptide proteomics and intact N-glycopeptide profiling to assign 47 of 50 ovarian cancer samples to two aligned molecular states, enabling subtype-linked glycan remodeling.
- Why it matters: Cancer-associated glycosylation varies across macro- and microheterogeneity, making it hard to resolve cohort-level disease remodeling and subtype structure from serum.
- What they did: In serum from 100 participants (23 healthy controls, 27 benign ovarian disease, 50 ovarian cancer), the study profiled 12,634 intact NGPs and built a Differential-Trend-Subtype framework combining cancer-vs-nonmalignant differences, healthy-to-benign-to-cancer trends, and within-cancer subtype effects.
- The result: Under leakage-controlled nested resampling, the best diagnostic panel reached ROC-AUC 0.843+-0.026, while the best subtype panel reached ROC-AUC 0.997+-0.005, with C1-high features more fucosylated and C2-high features more sialylated.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.